1. Interleukin-2 augments natural killer cell activity
2. Interleukin‐2 is both necessary and sufficient for the growth and differentiation of lectin‐stimulated cytolytic T‐lymphocyte precursors;Erard F;J Immunol,1985
3. Interleukin-2: Inception, Impact, and Implications
4. Synergistic antitumor effects of combination immunotherapy with recombinant interleukin‐2 and a recombinant hybrid interferon‐alpha in treatment of established murine hepatic me‐tastases;Cameron RB;Cancer Res,1988
5. Adoptive immunotherapy of murine hepatic metastases with lymphokine activated killer (LAK) cells and recombinant interleukin‐2 (rIL‐2) can mediate the regression of both immunogenic and non‐immunogenic sarcomas and an adenocarcinoma;Lafreniere R;J Immunol,1985